Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2019-09-30 Regulatory Filings
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) meeting (기업설명회). It provides the date, time, location, and purpose of the meeting, which is a standard regulatory disclosure for companies listed on the Korea Exchange. Since it announces the event and the availability of materials rather than being the presentation itself, and fits the regulatory disclosure pattern for corporate events, it is classified as a Regulatory Filing (RNS).
2019-09-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateralized shares and changes in the status of major shareholders. This falls under the category of 'Major Shareholding Notification' (MRQ).
2019-09-11 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure regarding the termination of a single sales and supply contract. It details the contract amount, the counterparty, the reason for termination, and the financial impact on the company. This type of disclosure is a standard regulatory filing in the Korean market (KRX) for material events that do not fall into specific categories like M&A or share issues, thus it is classified as a Regulatory Filing (RNS).
2019-08-22 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) by the company Pangen. It details the contract value, the counterparty, the contract period, and the nature of the services provided. Since this is a specific regulatory disclosure regarding a business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2019-08-22 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'PanGen' (주)팬젠 for the period 2019.01.01 to 2019.06.30. It contains detailed financial information, business descriptions, and management disclosures, which fits the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider trading or changes in shareholdings by company directors and executives. Based on the provided categories, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2019-07-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.